SEP 21, 2021 8:00 AM PDT

1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies

WRITTEN BY: Tara Fernandez

One in five hospitalized COVID-19 patients go on to develop autoantibodies—immune molecules that mistakenly target the body’s own tissues, says a new study. These antibodies, which can go on to cause autoimmune disease, were detected as early as a few days following hospitalization. The study was published in Nature Communications.

Scientists from Stanford Medicine analyzed blood samples from nearly 150 patients who were admitted for COVID-19 in search of autoantibodies. In particular, the team was interested in antibodies that specifically latched onto cytokines. 

The word “cytokine” originates from two Greek words: “cyto”, or cell, and “kinos”, meaning movement. These cell signaling molecules are part of the immune system’s sophisticated communication network, involved in coordinating responses to infections.

The researchers found that over 60 percent of all the COVID-19 patients studied had anti-cytokine antibodies, compared to just 15 percent of healthy controls. They hypothesize that because COVID-19 triggers a full-blown, often exaggerated inflammatory response, high circulating cytokine levels may spark the production of autoantibodies against them.

These anti-cytokine antibodies have the potential to make COVID symptoms much worse. If antibodies stop cytokines from functioning properly, virus-clearing immune mechanisms may become impaired, giving the virus the upper hand.

PJ Utz, study lead and professor of immunology at Stanford Medicine, says these findings further support why COVID-19 vaccinations are so critical. “It’s possible that, in the course of a poorly controlled SARS-CoV-2 infection—in which the virus hangs around for too long while an intensifying immune response continues to break viral particles into pieces—the immune system sees bits and pieces of the virus that it hadn’t previously seen,” Utz said. 

“If any of these viral pieces too closely resemble one of our own proteins, this could trigger autoantibody production.”

 

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 06, 2021
Immunology
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
JUL 06, 2021
New Nanotechnology Delivers RNA Drugs Only to "Bad" Immune Cells
Inflammatory conditions are linked to an overactive immune system, and resolving them therapeutically often involves cal ...
JUL 26, 2021
Cell & Molecular Biology
Cells Have a Self-Defense Mechanism Against Bacteria
JUL 26, 2021
Cells Have a Self-Defense Mechanism Against Bacteria
There are natural detergents that cells can use to defend themselves from pathogens. Scientists have now identified a pr ...
AUG 18, 2021
Cannabis Sciences
Cannabis Use Disorder Linked to COVID Hospitalization
AUG 18, 2021
Cannabis Use Disorder Linked to COVID Hospitalization
People with a genetic predisposition to cannabis use disorder (CUD) are more likely to require hospitalization after con ...
AUG 23, 2021
Microbiology
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
AUG 23, 2021
During a Chronic Viral Infection, Immune Cells May Suffer 'Exhaustion'
Several viruses are known to cause chronic infections, one is hepatitis C virus (HCV). Researchers studying these infect ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
SEP 23, 2021
Cardiology
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
SEP 23, 2021
Curbing Adverse Cardiovascular Outcomes Through Influenza Vaccination
Influenza is a severe infectious disease. According to the Centers for Disease Control and Prevention the H1N1 strain of ...
Loading Comments...